In Children, Does Using a Synera Patch Decrease Pain When Injecting Propofol at Anesthesia Induction?
NCT01576770 is a phase 4 interventional trial sponsored by The University of Texas Health Science Center, Houston. As of 18 Nov 2026, it has a status the registry marks as unknown. It studies Gebauer's Ethyl Chloride in Pain on Propofol IV Injection. The registry lists an enrollment of 80 participants at 1 site in 1 country. The registry lists a start date of 30 Apr 2012 and a primary completion date of 31 Oct 2012.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT01576770 |
| Status | Unknown |
| Phase | Phase 4 |
| Study type | Interventional trial |
| Lead sponsor | The University of Texas Health Science Center, Houston |
| Enrollment | 80 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Pain on Propofol IV Injection |
| Drugs | Gebauer's Ethyl Chloride |
| Start | 30 Apr 2012 |
| Primary completion | 31 Oct 2012 |
| Study completion | 31 Jan 2013 |
| Last update posted | 12 Apr 2012 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Samia N Khalil, M.D.
University of Texas Health Sciences Center at Houston
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Memorial Herman Hospital
Houston
Recruiting
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT01576770
Each answer restates registry values shown on this page.
What is NCT01576770?
NCT01576770 is a phase 4 interventional trial sponsored by The University of Texas Health Science Center, Houston. It studies Gebauer's Ethyl Chloride in Pain on Propofol IV Injection.
Who leads NCT01576770?
The registry names Samia N Khalil, M.D. (principal investigator, University of Texas Health Sciences Center at Houston) as the overall official.
Where does NCT01576770 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
Which drugs does NCT01576770 study?
The registered drug and biological interventions are Gebauer's Ethyl Chloride.
When is NCT01576770 expected to complete?
The registry lists a primary completion date of 31 Oct 2012 and a study completion date of 31 Jan 2013. The sponsor last updated the record on 12 Apr 2012.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.